Viral infections are a frequent occurrence following transfusion of blood products. While generally benign, these infections are capable of causing significant morbidity and mortality. Therefore, it is prudent to follow several general approaches diligently to reduce the risks of these infections in patients undergoing transfusions of blood products. These suggested measures include the following: 1. 1. Prescribe and administer blood and blood products only when absolutely needed. 2. 2. Use volunteer blood donors only. 3. 3. Avoid use of pooled blood products when possible. 4. 4. Use only blood and blood products that have been appropriately tested for HBsAg and HIV. 5. 5. Use ALT determinations to screen blood products and eliminate those with high level. 6. 6. Avoid the use of clotting-factor concentrates but, if necessary, use only those which have been heat-treated. 7. 7. Limit use of leukocyte transfusion. 8. 8. Use only CMV seronegative blood and blood products or frozen deglycerolized red cells in patients at high risk for posttransfusion CMV infection. © 1987.